Depomed (DEPO) Cash Flow Statement

Click line-items for a historical chart and %

Net income (loss)	-44.35M
Depreciation and amortization	83.02M
Loss on disposal of property and equipment	0
Stock-based compensation	12.6M
Accounts receivable	-15.83M
Inventories	-1.52M
Prepaid and other assets
Accounts payable and other accrued liabilities
Accrued compensation
Deferred revenue
Net cash provided by (used in) operating activities
Purchases of property and equipment	-2.79M
Purchases of marketable securities
Maturities of marketable securities	108.21M
Sales of marketable securities
Net cash provided by (used in) investing activities
Principal payments on long-term debt
Proceeds from issuance of common stock	6.79M
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period	101.08M
Cash and cash equivalents at end of period	90.36M

Entities mentioned with DEPO

View All Entities